X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse IPCA Labs with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

IPCA LABS vs ADCOCK INGRAM (S. Africa) - Comparison Results

IPCA LABS    Change

Ipca Laboratories is an integrated pharmaceutical company with presence in intermediates, APIs and formulations. The company has a strong focus on exports, catering to the US, Europe and the semi-regulated markets of the CIS, Africa and Asia. The com... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 IPCA LABS   ADCOCK INGRAM
EQUITY SHARE DATA
    IPCA LABS
Mar-17
ADCOCK INGRAM
Jun-14
IPCA LABS/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs643381-   
Low Rs503275-   
Sales per share (Unadj.) Rs254.4113.4-  
Earnings per share (Unadj.) Rs16.1-28.6-  
Cash flow per share (Unadj.) Rs29.8-23.7-  
Dividends per share (Unadj.) Rs1.000-  
Dividend yield (eoy) %0.20-  
Book value per share (Unadj.) Rs194.689.0-  
Shares outstanding (eoy) m126.20168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x2.32.9 77.8%   
Avg P/E ratio x35.7-11.5 -310.5%  
P/CF ratio (eoy) x19.2-13.9 -138.9%  
Price / Book Value ratio x2.93.7 79.9%  
Dividend payout %6.20-   
Avg Mkt Cap Rs m72,30055,398 130.5%   
No. of employees `00013.34.3 309.9%   
Total wages/salary Rs m6,9603,477 200.2%   
Avg. sales/employee Rs Th2,413.54,459.9 54.1%   
Avg. wages/employee Rs Th523.2809.9 64.6%   
Avg. net profit/employee Rs Th152.4-1,123.8 -13.6%   
INCOME DATA
Net Sales Rs m32,10619,146 167.7%  
Other income Rs m226134 168.3%   
Total revenues Rs m32,33219,280 167.7%   
Gross profit Rs m4,448-3,318 -134.1%  
Depreciation Rs m1,730826 209.3%   
Interest Rs m241519 46.4%   
Profit before tax Rs m2,703-4,529 -59.7%   
Minority Interest Rs m0-13 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m675283 238.6%   
Profit after tax Rs m2,028-4,824 -42.0%  
Gross profit margin %13.9-17.3 -79.9%  
Effective tax rate %25.0-6.2 -399.7%   
Net profit margin %6.3-25.2 -25.1%  
BALANCE SHEET DATA
Current assets Rs m17,34014,023 123.7%   
Current liabilities Rs m9,5597,890 121.2%   
Net working cap to sales %24.232.0 75.7%  
Current ratio x1.81.8 102.1%  
Inventory Days Days100111 90.4%  
Debtors Days Days57124 45.9%  
Net fixed assets Rs m20,7798,174 254.2%   
Share capital Rs m25289 283.9%   
"Free" reserves Rs m24,4990-   
Net worth Rs m24,55315,028 163.4%   
Long term debt Rs m3,5175,281 66.6%   
Total assets Rs m39,59528,389 139.5%  
Interest coverage x12.2-7.7 -158.1%   
Debt to equity ratio x0.10.4 40.8%  
Sales to assets ratio x0.80.7 120.2%   
Return on assets %5.7-15.2 -37.8%  
Return on equity %8.3-32.1 -25.7%  
Return on capital %10.5-19.8 -52.9%  
Exports to sales %48.60-   
Imports to sales %14.20-   
Net fx Rs m9,7900-   
CASH FLOW
From Operations Rs m2,7641,634 169.1%  
From Investments Rs m-1,432-502 285.3%  
From Financial Activity Rs m-1,5914,793 -33.2%  
Net Cashflow Rs m-2595,925 -4.4%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 5.26 Rs / ZAR

Compare IPCA LABS With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare IPCA LABS With: ALEMBIC LTD  UNICHEM LAB  PLETHICO PHARMA  WYETH LTD  CIPLA  



Today's Market

Sensex, Nifty Close at Record Highs; Bank & Realty Stocks Rally(Closing)

After opening the day marginally higher, Indian share markets extended gains in the afternoon session after the government decided to cut tax rates on certain products and services.

Related Views On News

Sun Pharma: Tough US Scenario Continues to Hit Business (Quarterly Results Update - Detailed)

Nov 20, 2017

The company's India business recovers but the pricing pressure and USFDA issues continue to mar the US revenues.

Dr Reddy's: No Respite from Pricing Pressure in the US (Quarterly Results Update - Detailed)

Nov 13, 2017

Pricing pressure continued to haunt Dr Reddy's although there was a significant improvement in its businesses sequentially.

Cipla: Strong Recovery Post GST (Quarterly Results Update - Detailed)

Nov 10, 2017

Cipla's India business recovers strongly this quarter post the GST issues in the first quarter of this fiscal.

Glenmark: Most Geographies Show Weak Growth (Quarterly Results Update - Detailed)

Nov 7, 2017

Poor show in the US, Latam and India hit profits during the quarter.

Lupin: US Markets Drags down Revenues and Net Profits (Quarterly Results Update - Detailed)

Nov 2, 2017

Domestic markets registers robust growth in the quarter

More Views on News

Most Popular

Retail Investors or Chickens Waiting to Get Slaughtered in the Stock Market?(Vivek Kaul's Diary)

Jan 9, 2018

The price to earnings ratio of the Nifty 50 is very close to all-time high levels.

Best ELSS Funds In 2018: Don't Blindly Chase Top Performers(Outside View)

Jan 10, 2018

As the tax-saving season begins, investors hunt for the best ELSS funds for 2018. PersonalFN provides a list of the top ELSS mutual funds of the past year.

Bitcoin Beginners Should Do These Three Things...(Smart Contrarian)

Jan 10, 2018

Three simple points to keep in mind before you consider buying bitcoin.

Resolutions for 2018 - by others(The Honest Truth)

Jan 8, 2018

Ten quirky new year resolutions. Guess by whom?

Did GST and Notebandi Help? Sherlock Holmes Finds Out...(The 5 Minute Wrapup)

Jan 13, 2018

Discussions with my cousin helped me understand the situation on Ground Zero - after the demonetization and GST upheaval. Here's what that means for listed companies...

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

IPCA LABS SHARE PRICE


Jan 19, 2018 (Close)

TRACK IPCA LABS

  • Track your investment in IPCA LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

COMPARE IPCA LABS WITH

MARKET STATS